Discover Astex
Our Mission & Values
Our Leadership Team
Our History
Corporate Social Responsibility
R&D
Clinical Pipeline
Proprietary Products and Programs
Tolinapant (ASTX660) – Solid Tumors & Lymphomas
ASTX029 Extracellular Signal-Related Protein Kinases (ERK 1/2) Inhibitor (Solid Tumors)
ASTX295 Oral Murine Double Minute 2 (MDM2) antagonist (Solid Tumors)
Partnered Products and Programs
Kisqali
®
(ribociclib) CDK4/6 inhibitor (Oncology)
Balversa
®
(erdafitinib) FGFr inhibitor (Oncology)
Truqap™ PKB/Akt Inhibitor (Oncology)
Multiple Targets and Therapeutic Areas
Pyramid™ Discovery Platform
Oncology and CNS Discovery
Sustaining Innovation Postdocs
Partnering
Our People & Culture
Career Opportunities
Media
Press Releases
Conferences & Meetings
Presentations & Publications
Interactive Scientific Resources
Interactive Software
Astex in the News
Contact
Search
Menu
Menu
You are here:
Home
1
/
Search results for ""
New Search
If you are not happy with the results below please do another search
Scroll to top